Journal Articles (past 5 years) – Marc Brisson https://marc-brisson.net Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Disease Fri, 01 May 2026 17:31:20 +0000 en-US hourly 1 Google Scholar https://marc-brisson.net/publication/google-scholar/ Mon, 05 Oct 2020 17:52:11 +0000 https://beta.marc-brisson.net/?post_type=publications&p=534 Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study https://marc-brisson.net/publication/substantial-increases-in-cervical-cancer-inequalities-worldwide-without-enhanced-human-papillomavirus-vaccination-and-screening-efforts-a-global-modelling-study/ Fri, 01 May 2026 17:31:20 +0000 https://marc-brisson.net/?post_type=publications&p=2125 Brisson M, Drolet M, Gingras G, Laprise JF, Chamberland É, Bruni L, Sabourin AA, Bénard É, Ndiaye, Barnabas RV

The Lancet 2026;407(10540):1726-37

]]> Single-dose HPV vaccination in the United States — a multi-modeling analysis https://marc-brisson.net/publication/single-dose-hpv-vaccination-in-the-united-states-a-multi-modeling-analysis/ Mon, 12 Jan 2026 12:00:16 +0000 https://marc-brisson.net/?post_type=publications&p=2086 Burger EA, Laprise JF, Spencer JC, Sy S, Regan MC, Drolet M, Chamberland E, Brisson M, Kim JJ

Lancet Reg Health Am 2026;55:101361

https://www.sciencedirect.com/science/article/pii/S2667193X25003722

]]> Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis https://marc-brisson.net/publication/ranking-the-most-efficient-human-papillomavirus-vaccination-strategies-in-low-income-and-lower-middle-income-countries-a-mathematical-modelling-analysis/ Thu, 13 Nov 2025 15:54:04 +0000 https://marc-brisson.net/?post_type=publications&p=2046 Bénard É, Drolet M, Gingras G, Laprise J-F, Sabourin A-A, Bloem P, Akaba H, Brotherton J, Jit M, Brisson M

The Lancet Global Health. 2025;13(12):e2153-e2164

]]> Author response to commentary on “Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States” https://marc-brisson.net/publication/author-response-to-commentary-on-cost-effectiveness-of-extending-human-papillomavirus-vaccination-to-population-subgroups-older-than-26-years-who-are-at-higher-risk-for-human-papillomavirus-infectio/ Tue, 18 Nov 2025 16:55:35 +0000 https://marc-brisson.net/?post_type=publications&p=2071 Laprise JF, Chessin HW, Markowitz LE, Drolet M, Brisson M

Ann Intern Med. 2025 Jan;178(1):50-58. Author Response to Boeder et al. 29 September 2025.

]]> Quadrivalent HPV Vaccine Evaluation Study with Addition of the Nonavalent Vaccine (QUEST-ADVANCE): protocol of an observational cohort study https://marc-brisson.net/publication/quadrivalent-hpv-vaccine-evaluation-study-with-addition-of-the-nonavalent-vaccine-quest-advance-protocol-of-an-observational-cohort-study/ Thu, 13 Nov 2025 15:42:14 +0000 https://marc-brisson.net/?post_type=publications&p=2042 Middeldorp M, Donken R, Nirmal A, Smith B, Citlali Marquez A, Bettinger JA, Brisson M, Burchell AN, Dobson SR, Dawar M, Franco EL, Grennan T, Krajden M, Mayrand M-H, McNeil Shelly, Naus M, Sauvageau C, Singer J, Smith LW, Ogilvie GS, Sadarangani M

BMJ Open. 2025;15:e100560

]]> Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States https://marc-brisson.net/publication/cost-effectiveness-of-extending-human-papillomavirus-vaccination-to-population-subgroups-older-than-26-years-who-are-at-higher-risk-for-human-papillomavirus-infection-in-the-united-states/ Tue, 26 Nov 2024 12:35:19 +0000 https://marc-brisson.net/?post_type=publications&p=1945 Laprise JF, Chesson HW, Markowitz LE, Drolet M, Brisson M

Ann Intern Med 2024. doi:10.7326/M24-0421

]]> Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling https://marc-brisson.net/publication/population-level-impact-of-switching-to-1-dose-human-papillomavirus-vaccination-in-high-income-countries-examining-uncertainties-using-mathematical-modeling/ Mon, 18 Nov 2024 14:27:22 +0000 https://marc-brisson.net/?post_type=publications&p=1912 Brisson M, Laprise JF, Drolet M, Chamberland E, Benard E, Burger EA, Jit M, Kim JJ, Markowitz LE, Sauvageau C, Sy S

J Natl Cancer Inst Monogr. 2024;2024(67):387-99

]]> Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting https://marc-brisson.net/publication/population-level-health-impact-of-hypothetical-waning-1-dose-human-papillomavirus-vaccination-and-2-dose-mitigation-strategies-in-a-high-cervical-cancer-burden-setting/ Mon, 18 Nov 2024 14:29:25 +0000 https://marc-brisson.net/?post_type=publications&p=1914 Burger EA, Laprise JF, Portnoy A, Spencer JC, Sy S, Regan MC, Benard E, Drolet M, Brisson M, Kim JJ

J Natl Cancer Inst Monogr. 2024;2024(67):379-86

]]> Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis https://marc-brisson.net/publication/switching-from-a-2-dose-to-a-1-dose-program-of-gender-neutral-routine-vaccination-against-human-papillomavirus-in-canada-a-mathematical-modelling-analysis/ Mon, 18 Nov 2024 14:22:18 +0000 https://marc-brisson.net/?post_type=publications&p=1909 Drolet M, Laprise JF, Chamberland E, Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M.

CMAJ 2024;196(33):E1136-E1143

]]> Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries https://marc-brisson.net/publication/optimal-human-papillomavirus-vaccination-strategies-in-the-context-of-vaccine-supply-constraints-in-100-countries/ Mon, 18 Nov 2024 14:56:05 +0000 https://marc-brisson.net/?post_type=publications&p=1916 Prem K, Cernuschi T, Malvolti S, Brisson M, Jit M

EClinicalMedicine 2024 Jul 18:74:102735

]]> Population immunity to varicella in Canada: A Canadian Immunization Research Network (CIRN) study https://marc-brisson.net/publication/population-immunity-to-varicella-in-canada-a-canadian-immunization-research-network-cirn-study/ Mon, 18 Nov 2024 19:37:08 +0000 https://marc-brisson.net/?post_type=publications&p=1918 Wright J, Crowcroft N, McLachlan E, Perez-Iratxeta C, Joh E, Osman S. Hatchette T, Deeks SL, Wilson SE, Hughes SL, Halperin SA, Buchan SA, Ward BJ, Gubbay J, Brisson M, Serhir B, Severini A, Bolotin S

PLoS One. 2024;19(8):e0309154

]]> Association of naturally acquired type-specific HPV antibodies and subsequent HPV re-detection: systematic review and meta-analysis https://marc-brisson.net/publication/association-of-naturally-acquired-type-specific-hpv-antibodies-and-subsequent-hpv-re-detection-systematic-review-and-meta-analysis/ Mon, 13 Nov 2023 12:35:16 +0000 https://marc-brisson.net/publication/association-of-naturally-acquired-type-specific-hpv-antibodies-and-subsequent-hpv-re-detection-systematic-review-and-meta-analysis/ Yokoji K, Giguère K, Malagón T, Rönn MM, Mayaud P, Kelly H, Delany-Moretlwe S, Drolet M, Brisson M, Boily MC, Maheu-Giroux M

Infect Agents Cancer 18, 70 (2023). https://doi.org/10.1186/s13027-023-00546-3

]]> Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis https://marc-brisson.net/publication/potential-population-level-effectiveness-of-one-dose-hpv-vaccination-in-low-income-and-middle-income-countries-a-mathematical-modelling-analysis/ Fri, 29 Sep 2023 10:59:35 +0000 https://marc-brisson.net/?post_type=publications&p=1792 Bénard É, Drolet M, Laprise JF, Gingras G, Jit M, Boily MC, Bloem P, Brisson M

Lancet PH 2023;8(10):e788-e799 https://doi.org/10.1016/S2468-2667(23)00180-9

]]> Global impact and cost‑effectiveness of one‑dose versus two‑dose human papillomavirus vaccination schedules: a comparative modelling analysis https://marc-brisson.net/publication/global-impact-and-cost%e2%80%91effectiveness-of-one%e2%80%91dose-versus-two%e2%80%91dose-human-papillomavirus-vaccination-schedules-a-comparative-modelling-analysis/ Mon, 28 Aug 2023 11:33:39 +0000 https://marc-brisson.net/?post_type=publications&p=1775 BMC Med 2023;21(313). https://doi.org/10.1186/s12916-023-02988-3

Prem K, Choi YH, Bénard É, Burger EA, Hadley L, Laprise JF, Regan MC, Drolet M, Sy S, Abbas K, Portnoy A, Kim JJ, Brisson M, Jit M

]]> Regional and country-level trends in cervical cancer screening coverage in sub-Saharan Africa: A systematic analysis of population-based surveys (2000–2020) https://marc-brisson.net/publication/regional-and-country-level-trends-in-cervical-cancer-screening-coverage-in-sub-saharan-africa-a-systematic-analysis-of-population-based-surveys-2000-2020/ Mon, 13 Feb 2023 14:43:48 +0000 https://marc-brisson.net/?post_type=publications&p=1701 Yang L, Boily MC, Rönn MM, Obiri-Yeboah D, Morhason-Bello I, Meda N, Lompo O, Mayaud P, Pickles M, Brisson M, Hodgins C, Delany-Moretlwe S, Maheu-Giroux M

PLoS medicine 2023;20(1):e1004143 https://doi.org/10.1371/journal.pmed.1004143

]]> Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis https://marc-brisson.net/publication/potential-benefit-of-extended-dose-schedules-of-human-papillomavirus-vaccination-in-the-context-of-scarce-resources-and-covid-19-disruptions-in-low-income-and-middle-income-countries-a-mathematical-m/ Wed, 14 Dec 2022 12:49:06 +0000 https://marc-brisson.net/?post_type=publications&p=1685 Bénard E, Drolet M, Laprise JF, Jit M, Prem K, Boily MC, Brisson M

Lancet Global Health 2023;11(1):e48-58.

]]> Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study https://marc-brisson.net/publication/protection-against-omicron-b-1-1-529-ba-2-reinfection-conferred-by-primary-omicron-ba-1-or-pre-omicron-sars-cov-2-infection-among-health-care-workers-with-and-without-mrna-vaccination-a-test-negati/ Thu, 22 Sep 2022 11:34:04 +0000 https://marc-brisson.net/?post_type=publications&p=1620 Carazo S, Skowronski DM, Brisson M, Barkati S, Sauvageau C, Brousseau N, Gilca R, Fafard J, Talbot D, Ouakki M, Gilca V, Carignan A, Deceuninck G, De Wals P, De Serres G

The Lancet ID 2023;23(1):45-55. https://doi.org/10.1016/S1473-3099(22)00578-3.

]]> Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada https://marc-brisson.net/publication/1703/ Mon, 13 Feb 2023 14:53:26 +0000 https://marc-brisson.net/?post_type=publications&p=1703 Skowronski DM, Febriani Y, Ouakki M, Setayeshgar S, El Adam S, Zou M, Talbot D, Prystajecky N, Tyson JR, Gilca R, Brousseau N, Deceuninck G, Galanis E, Fjell CD, Sbihi H, Fortin E, Barkati S, Sauvageau C, Naus M, Patrick DM, Henry B, Hoang LMN, De Wals P, Garenc C, Carignan A, Drolet M, Jassem AN, Sadarangani M, Brisson M, Krajden M, De Serres G

Clinical Infectious Diseases 2022;75(11):1980–1992 https://doi.org/10.1093/cid/ciac290

]]> Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening https://marc-brisson.net/publication/estimating-the-effect-of-hiv-on-cervical-cancer-elimination-in-south-africa-comparative-modelling-of-the-impact-of-vaccination-and-screening/ Tue, 22 Nov 2022 13:29:43 +0000 https://marc-brisson.net/?post_type=publications&p=1655 eClinicalMedicine 2022, Nov. 17;101754 https://doi.org/10.1016/j.eclinm.2022.101754

Boily MC, Barnabas RV, Rönn MM, Bayer CJ, Schalkwyk C, Sonia N, Rao DW, Staadegaard L, Liu G, Silhol R, Brisson M, Johnson LF, Bloem P, Gottlieb S, Broutet N, Dalal S

]]> Prevalence and risk factors for human papillomavirus infection among female sex workers in Hanoi and Ho Chi Minh City, Viet Nam: a cross-sectional study – Prevalence and risk factors for HPV among FSWs in Viet Nam https://marc-brisson.net/publication/prevalence-and-risk-factors-for-human-papillomavirus-infection-among-female-sex-workers-in-hanoi-and-ho-chi-minh-city-viet-nam-a-cross-sectional-study-prevalence-and-risk-factors-for-hpv-among-fsw/ Fri, 09 Dec 2022 14:35:45 +0000 https://marc-brisson.net/?post_type=publications&p=1669 Pham QD, Prem K, Le TA, Trang NV, Jit M, Nguyen TA, Cao V, Le-Ha TD, Chu MTN, Le LTK, Toh ZQ, Brisson M, Garland S, Murray G, Bright K, Dang DA, Tran HP, Mulholland EK

Western Pac Surveill Response J 2022;13(4):1-11. doi: 10.5365/wpsar.2022.13.4.894 [ WHO ]

]]> Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis https://marc-brisson.net/publication/immunogenicity-safety-and-efficacy-of-the-hpv-vaccines-among-people-living-with-hiv-a-systematic-review-and-meta-analysis/ Tue, 22 Nov 2022 13:43:24 +0000 https://marc-brisson.net/?post_type=publications&p=1661 eClinicalMedicine 2022;52:101585 https://doi.org/10.1016/j.eclinm.2022.101585

Staadegaard L, Rönn MM, Soni N, Bellerose ME, Bloem P, Brisson M, Maheu-Giroux M, Barnabas RV, Drolet M, Mayaud P, Dalal S, Boily MC

]]> Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada https://marc-brisson.net/publication/estimated-protection-of-prior-sars-cov-2-infection-against-reinfection-with-the-omicron-variant-among-messenger-rna-vaccinated-and-nonvaccinated-individuals-in-quebec-canada/ Fri, 14 Oct 2022 16:18:11 +0000 https://marc-brisson.net/?post_type=publications&p=1639 Carazo S, Skowronski DM, Brisson, M.

JAMA Netw Open. 2022;5(10):e2236670. doi:10.1001/jamanetworkopen.2022.36670

]]> Letter to the Editor: Recent economic evaluation of 1-dose HPV vaccination uses unsupported assumptions https://marc-brisson.net/publication/letter-to-the-editor-recent-economic-evaluation-of-1-dose-hpv-vaccination-uses-unsupported-assumptions/ Sat, 13 Aug 2022 14:58:06 +0000 https://marc-brisson.net/?post_type=publications&p=1597 Burger E, Baussano I, Kim JJ, Laprise JF, Berkhof J, Schiller JT, Canfell K, Prem K, Brisson M, Jit M, Barnabas RV

Vaccine 2022. https://doi.org/10.1016/j.vaccine.2022.07.022

]]> Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs https://marc-brisson.net/publication/human-papillomavirus-vaccine-effectiveness-by-number-of-doses-updated-systematic-review-of-data-from-national-immunization-programs/ Thu, 01 Sep 2022 11:55:07 +0000 https://marc-brisson.net/?post_type=publications&p=1613 Markowitz LE, Drolet M, Lewis RM, Lemieux-Mellouki P, Pérez N, Jit M, Brotherton JM, Ogilvie, G Kreimer AR, Brisson M.

Vaccine 2022;S0264-410X(22)00834-9. doi: 10.1016/j.vaccine.2022.06.065. Online ahead of print.

[ PubMed ]

]]> Review of the current published evidence on single-dose HPV vaccination 4th Edition https://marc-brisson.net/publication/review-of-the-current-published-evidence-on-single-dose-hpv-vaccination-4th-edition/ Fri, 10 Jun 2022 14:54:56 +0000 https://marc-brisson.net/publication/review-of-the-current-published-evidence-on-single-dose-hpv-vaccination-4th-edition/ PATH. May 2022.

Single dose HPV vaccine evaluation consortium [ PATH ]

]]> Time trends in social contacts of individuals according to comorbidity and vaccination status, before and during the COVID-19 pandemic https://marc-brisson.net/publication/time-trends-in-social-contacts-of-individuals-according-to-comorbidity-and-vaccination-status-before-and-during-the-covid-19-pandemic/ Thu, 26 May 2022 12:17:57 +0000 https://marc-brisson.net/?post_type=publications&p=1550 BMC Medicine 2022;20:199. https://doi.org/10.1186/s12916-022-02398-x

Godbout A, Drolet M, Mondor M, Simard M, Sauvageau C, De Serres G, Brisson M

]]> Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study https://marc-brisson.net/publication/time-trends-in-social-contacts-before-and-during-the-covid-19-pandemic-the-connect-study-2/ Thu, 26 May 2022 12:16:48 +0000 https://marc-brisson.net/?post_type=publications&p=1548 BMC Public Health 2022;22:1032. https://doi.org/10.1186/s12889-022-13402-7

Drolet M, Godbout A, Mondor M, Béraud G, Drolet-Roy L, Lemieux-Mellouki P, Bureau A, Demers É, Boily MC, Sauvageau C, De Serres G, Hens N, Beutels P, Dervaux B, Brisson M

]]> Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting https://marc-brisson.net/publication/now-or-later-health-impacts-of-delaying-single-dose-hpv-vaccine-implementation-in-a-high-burden-setting/ Tue, 17 May 2022 14:11:38 +0000 https://marc-brisson.net/?post_type=publications&p=1532 Int J Cancer 2022. doi:10.1002/ijc.34054. Online ahead of print.

Burger EA, Laprise JF, Sy S, Regan MC, Prem K, Jit M, Brisson M, Kim JJ.

]]> Mortality trends and length of stays among hospitalized patients with COVID-19 in Ontario and Québec (Canada): a population-based cohort study of the first three epidemic waves https://marc-brisson.net/publication/mortality-trends-and-length-of-stays-among-hospitalized-patients-with-covid-19-in-ontario-and-quebec-canada-a-population-based-cohort-study-of-the-first-three-epidemic-waves/ Tue, 17 May 2022 14:13:04 +0000 https://marc-brisson.net/?post_type=publications&p=1534 Int J Infect Dis 2022;121:1-10. doi:10.1016/j.ijid.2022.04.048. Online ahead of print.

Xia Y, Ma H, Buckeridge DL, Brisson M, Sander B, Chan A, Verma A, Ganser I, Kronfli N, Mishra S, Maheu-Giroux M.

]]> Population immunity to measles in Canada using Canadian Health Measures survey data – A Canadian Immunization Research Network (CIRN) study https://marc-brisson.net/publication/population-immunity-to-measles-in-canada-using-canadian-health-measures-survey-data-a-canadian-immunization-research-network-cirn-study/ Tue, 17 May 2022 14:09:35 +0000 https://marc-brisson.net/?post_type=publications&p=1530 Vaccine 2022;40(23):3228-35. doi: 10.1016/j.vaccine.2022.04.011. Epub 2022 Apr 28.

Osman S, Crowcroft N, McLachlan E, Hatchette T, Pere-Iratxeta C, Joh E, Wright J, Halperin SA, Deeks S, Wilson S, Buchan S, Ward B, Gubbay J, Brisson M, Serhir B, Severini A, Bolotin S

]]> Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada https://marc-brisson.net/publication/single-dose-mrna-vaccine-effectiveness-against-sars-cov-2-in-healthcare-workers-extending-16-weeks-post-vaccination-a-test-negative-design-from-quebec-canada/ Fri, 22 Apr 2022 17:37:48 +0000 https://marc-brisson.net/?post_type=publications&p=1518 Carazo S, Talbot D, Boulianne N, Brisson M, Gilca R, Deceuninck G, Brousseau N, Drolet M, Ouakki M, Sauvageau C, Barkati S, Fortin E, Carignan A, De Wals P, Skowronski DM, De Serres G.
Clin Infect Dis . 2021 Aug 30;ciab739. doi: 10.1093/cid/ciab739. Online ahead of print.

]]> Geographic concentration of SARS-CoV-2 cases by social determinants of health in metropolitan areas in Canada: a cross-sectional study https://marc-brisson.net/publication/geographic-concentration-of-sars-cov-2-cases-by-social-determinants-of-health-in-metropolitan-areas-in-canada-a-cross-sectional-study/ Mon, 28 Feb 2022 14:21:36 +0000 https://marc-brisson.net/?post_type=publications&p=1501 Xia Y, Ma H, Moloney G, Velásquez García HA, Sirski M, Janjua NZ, Vickers D, Williamson T, Katz A, Yiu K, Kustra R, Buckeridge DL, Brisson M, Baral SD, Mishra S, Maheu-Giroux M

CMAJ 2022;194(6):E195-E204. doi: 10.1503/cmaj.211249

]]> Potential Benefit of Extended Dose Schedules of Human Papillomavirus (HPV) Vaccination in the Context of Limited Resources and COVID-19 Disruptions in Low- and Middle-Income Countries: A Mathematical Modeling Analysis. https://marc-brisson.net/publication/potential-benefit-of-extended-dose-schedules-of-human-papillomavirus-hpv-vaccination-in-the-context-of-limited-resources-and-covid-19-disruptions-in-low-and-middle-income-countries-a-mathematical/ Fri, 18 Feb 2022 14:38:59 +0000 https://marc-brisson.net/publication/potential-benefit-of-extended-dose-schedules-of-human-papillomavirus-hpv-vaccination-in-the-context-of-limited-resources-and-covid-19-disruptions-in-low-and-middle-income-countries-a-mathematical/ Anal human papillomavirus prevalence and risk factors among men who have sex with men in Vietnam https://marc-brisson.net/publication/anal-human-papillomavirus-prevalence-and-risk-factors-among-men-who-have-sex-with-men-in-vietnam/ Fri, 03 Dec 2021 19:26:53 +0000 https://marc-brisson.net/?post_type=publications&p=1439 Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study https://marc-brisson.net/publication/time-trends-in-social-contacts-before-and-during-the-covid-19-pandemic-the-connect-study/ Thu, 07 Oct 2021 19:16:51 +0000 https://marc-brisson.net/?post_type=publications&p=1426 Drolet M, Godbout A, Mondor M, Drolet-Roy L, Beraud G, Lemmieux-Mellouki P, Demers E, Boily MC, Sauvageau C, De Serres G, Hens N, Beutels P, Dervaux B, Brisson M. MedRxiv doi: https://doi.org/10.1101/2021.10.06.21264632

]]> Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis https://marc-brisson.net/publication/optimal-human-papillomavirus-vaccination-strategies-to-prevent-cervical-cancer-in-low-income-and-middle-income-countries-in-the-context-of-limited-resources-a-mathematical-modelling-analysis/ Thu, 08 Jul 2021 12:07:03 +0000 https://marc-brisson.net/?post_type=publications&p=1408 Drolet M, Laprise JF, Martin D, Jit M, Bénard É, Gingras G, Boily MC, Alary M, Baussano I, Hutubessy R, Brisson M

Lancet Infect Dis 2021 https://doi.org/10.1016/S1473-3099(20)30860-4

]]> Assessing fitness-for-purpose and comparing the suitability of COVID-19 multi-country models for local contexts and users https://marc-brisson.net/publication/assessing-fitness-for-purpose-and-comparing-the-suitability-of-covid-19-multi-country-models-for-local-contexts-and-users/ Tue, 24 Aug 2021 12:37:18 +0000 https://marc-brisson.net/?post_type=publications&p=1413 Gates Open Research 2021;5(79):79

Clapham H, Gad M, Gheorghe A, Hutubessy R, Megiddo I, Painter C, Ruiz F, Cheikh N, Gorgens M, Wilkinson T, Brisson M, Gay N, Labadin J, McVernon J, Luz PM, Ndifon W, Nichols BE, Prinja S, Salomon J, Tshangela A

 

 

]]> Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019 https://marc-brisson.net/publication/human-papillomavirus-hpv-vaccine-uptake-among-a-community-recruited-sample-of-gay-bisexual-and-other-men-who-have-sex-with-men-in-the-three-largest-cities-in-canada-from-2017-to-2019/ Wed, 23 Jun 2021 19:01:01 +0000 https://marc-brisson.net/?post_type=publications&p=1400 From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness https://marc-brisson.net/publication/from-cervical-cancer-elimination-to-eradication-of-vaccine-type-human-papillomavirus-feasibility-public-health-strategies-and-cost-effectiveness/ Thu, 27 May 2021 18:26:45 +0000 https://marc-brisson.net/?post_type=publications&p=1373 The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018 https://marc-brisson.net/publication/the-estimated-lifetime-medical-cost-of-diseases-attributable-to-human-papillomavirus-infections-acquired-in-2018/ Fri, 26 Mar 2021 19:42:36 +0000 https://marc-brisson.net/?post_type=publications&p=1329 Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis https://marc-brisson.net/publication/global-impact-and-cost-effectiveness-of-one-dose-versus-two-dose-human-papillomavirus-vaccination-schedules-a-comparative-modelling-analysis/ Mon, 15 Feb 2021 13:53:14 +0000 https://marc-brisson.net/?post_type=publications&p=1298 MedRxiv

Prem K, Choi YH, Bénard E, Burger EA, Hadley L, Laprise JF, Regan C, Drolet M, Sy S, Abbas K, Kim JJ, Brisson M, Jit M

]]> The role of case importation in explaining differences in early SARS-CoV-2 transmission dynamics in Canada – A mathematical modeling study of surveillance data https://marc-brisson.net/publication/the-role-of-case-importation-in-explaining-differences-in-early-sars-cov-2-transmission-dynamics-in-canada-a-mathematical-modeling-study-of-surveillance-data/ Wed, 10 Feb 2021 13:44:38 +0000 https://marc-brisson.net/?post_type=publications&p=1291 Int J Inf Dis 2021;102:254-9

Godin A, Xia Y, Buckeridge DL, Mishra S, Douwes-Schultz D, Shen Y, Lavigne M, Drolet M, Schmidt AM, Brisson M, Maheu-Giroux M

]]> Estimated prevalence and incidence of disease-associated HPV types among 15-59-year-olds in the United States https://marc-brisson.net/publication/estimated-prevalence-and-incidence-of-disease-associated-hpv-types-among-15-59-year-olds-in-the-united-states/ Wed, 10 Feb 2021 13:29:58 +0000 https://marc-brisson.net/?post_type=publications&p=1287 Sex Transm Dis 2021; Volume Publish Ahead of Print – doi: 10.1097/OLQ.0000000000001356
Lewis RM, Laprise JF, Gargano JW, Unger ER, Querec TD, Chesson H, Brisson M, Markowitz LE

]]> Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study https://marc-brisson.net/publication/estimating-the-health-impact-of-vaccination-against-ten-pathogens-in-98-low-income-and-middle-income-countries-from-2000-to-2030-a-modelling-study/ Fri, 29 Jan 2021 03:23:44 +0000 https://marc-brisson.net/?post_type=publications&p=1275 Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study https://marc-brisson.net/publication/epidemiology-of-varicella-among-immigrants-and-non-immigrants-in-quebec-canada-before-and-after-the-introduction-of-childhood-varicella-vaccination-a-retrospective-cohort-study/ Tue, 26 Jan 2021 21:55:17 +0000 https://marc-brisson.net/?post_type=publications&p=1269 The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018 https://marc-brisson.net/publication/the-estimated-direct-lifetime-medical-costs-of-sexually-transmitted-infections-acquired-in-the-united-states-in-2018/ Mon, 25 Jan 2021 21:55:27 +0000 https://marc-brisson.net/?post_type=publications&p=1267 Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule https://marc-brisson.net/publication/continued-hpv-vaccination-in-the-face-of-unexpected-challenges-a-commentary-on-the-rationale-for-an-extended-interval-two-dose-schedule/ Wed, 13 Jan 2021 13:46:50 +0000 https://marc-brisson.net/?post_type=publications&p=1246 HPV vaccination and sexual behaviour in health care seeking young women in Luxembourg https://marc-brisson.net/publication/hpv-vaccination-and-sexual-behaviour-in-health-care-seeking-young-women-in-luxembourg/ Thu, 13 Nov 2025 19:41:18 +0000 https://marc-brisson.net/?post_type=publications&p=2050 Soudeyns C, NikoSpeybroeck N, Brisson M, Mossong J, Latsuzbaia A

PeerJ 2020;8:e8516 http://doi.org/10.7717/peerj.851

]]> Mortality reductions and lives saved on the path to eliminating cervical cancer in 78 Low and Lower-Middle Income Countries: Comparative modelling of impact of achieving WHO targets for scaling up vaccination, cervical screening and cancer treatment services https://marc-brisson.net/publication/mortality-reductions-and-lives-saved-on-the-path-to-eliminating-cervical-cancer-in-78-low-and-lower-middle-income-countries-comparative-modelling-of-impact-of-achieving-who-targets-for-scaling-up-vac/ Mon, 05 Oct 2020 17:52:11 +0000 https://beta.marc-brisson.net/?post_type=publications&p=531 Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. https://marc-brisson.net/publication/impact-of-hpv-vaccination-and-cervical-screening-on-cervical-cancer-elimination-a-comparative-modelling-analysis-in-78-low-income-and-lower-middle-income-countries/ Mon, 05 Oct 2020 17:52:11 +0000 https://beta.marc-brisson.net/?post_type=publications&p=532 Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study https://marc-brisson.net/publication/effects-of-updated-demography-disability-weights-and-cervical-cancer-burden-on-estimates-of-human-papillomavirus-vaccination-impact-at-the-global-regional-and-national-levels-a-prime-modelling-st/ Mon, 05 Oct 2020 17:52:11 +0000 https://beta.marc-brisson.net/?post_type=publications&p=533 Review of the current published evidence for single-dose HPV vaccination 2nd Edition: White Paper https://marc-brisson.net/publication/review-of-the-current-published-evidence-for-single-dose-hpv-vaccination-2nd-edition-white-paper/ Mon, 05 Oct 2020 17:52:12 +0000 https://beta.marc-brisson.net/?post_type=publications&p=524 Review of the current published evidence for single-dose HPV vaccination: White Paper https://marc-brisson.net/publication/review-of-the-current-published-evidence-for-single-dose-hpv-vaccination-white-paper/ Mon, 05 Oct 2020 17:52:11 +0000 https://beta.marc-brisson.net/?post_type=publications&p=518